Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-07-01T01:14:14.021Z Has data issue: false hasContentIssue false

Mid-cavitary hypertrophy after myocarditis in a patient with operated medulloblastoma

Published online by Cambridge University Press:  16 December 2022

Hazım Alper Gursu*
Affiliation:
Pediatric Cardiology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey
İbrahim İlker Çetin
Affiliation:
Pediatric Cardiology, Yildirim Beyazit University, Ankara, Turkey
*
Author for correspondence: Hazım Alper Gursu, Pediatric Cardiology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey. E-mail: hagursu@yahoo.com.tr

Abstract

A 16-month-old girl was referred for tachycardia and upper respiratory tract infection. Echocardiographic examination revealed pericardial effusion, mild mitral regurgitation, and left ventricle systolic dysfunction. Patient was positive for Parainfluenza type 4 virus. Her laboratory tests revealed increased troponin I level. The patient was treated with intravenous immunoglobulin considering acute viral myopericarditis. Two weeks after treatment, midventricular hypertrophy was detected.

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gersh, BJ, Maron, BJ, Bonow, RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783e831.Google Scholar
Noureldin, RA, Liu, S, Nacif, MS, et al. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 17.10.1186/1532-429X-14-17CrossRefGoogle ScholarPubMed
Kusumoto, S, Kawano, H, Takeno, M, et al. Cardiogenic shock due to left ventricular outflow obstruction and complete atrioventricular block in a patient with hypertrophic cardiomyopathy with acute myocarditis. Intern Med. 2012; 51: 25652571.10.2169/internalmedicine.51.8285CrossRefGoogle Scholar
Hiramitsu, S, Morimoto, S, Kato, S, et al. Transient ventricular wall thickening in acute myocarditis a serial echocardiographic and histopathologic study. Jpn Circ J 2001; 65: 863866.CrossRefGoogle ScholarPubMed
Higashikuni, Y, Tanaka, K, Kato, M, et al. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation. J Am Heart Assoc 2013; 18: 26.Google Scholar
Mahrholdt, H, Wagner, A, Deluigi, CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114: 15811590.CrossRefGoogle ScholarPubMed
Saba, SG, Ertel, AW, Siegenthaler, M, et al. Hemodynamic consequences of hypertrophic cardiomyopathy with midventricular obstruction: apical aneurysm and thrombus formation. J Gen Pract (Los Angel) 2014; 2: 161.CrossRefGoogle ScholarPubMed
Minami, Y, Kajimoto, K, Terajima, Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011; 57: 23462355.CrossRefGoogle ScholarPubMed
Tezuka, A, Higo, K, Nakamukae, Y, et al. Bisoprolol successfully improved the intraventricular pressure gradient in a patient with midventricular obstructive hypertrophic cardiomyopathy with an apex aneurysm due to apical myocardial damage. Intern Med 2019; 58: 535539.10.2169/internalmedicine.0997-18CrossRefGoogle Scholar